Aukett Swanke Group (AUK) Share Price, News & Analysis

Company Overview

Aukett Swanke Group has a strong foundation in architectural services and is on a transformative journey to become a London-listed provider of Smart Buildings and related services. ASG are uniquely positioned to ensure the technical systems that run modern premises are designed as an integral part of the structure, from the outset. Between March 2023 and March 2024 it completed four acquisitions which strengthen the Group's experience and expertise in the delivery of smart building technologies. The management look forward to reporting on progress. Investors may be interested to know that the Group enjoys strong support from current and former management and staff, with a sizeable minority of the shares in the hands of retired directors and staff. Since December 2023 regular purchases by current employees are made monthly under the group's All Employee Share Ownership Plan and senior staff have made additional commitments to make regular purchases of shares in the market, showing their commitment to the business.

Key Stats

• Today's Range: N/A
• 50-Day Range: 1.45 to 1.70
• 52-Week Range: N/A
• Volume: 88,410 shs
• Average Volume: 217,393 shs
• Market Capitalization: £5.46 million
• P/E Ratio: N/A
• Dividend Yield: 6.22%
• Price Target: N/A
• Consensus Rating: N/A

AUK Stock Analysis - Frequently Asked Questions

How do I buy shares of Aukett Swanke Group?

Shares of AUK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Aukett Swanke Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aukett Swanke Group investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Industrials
• Industry: Engineering & Construction
• Sub-Industry: Personal Services
• Current Symbol: LON:AUK
• CIK: N/A
• Web: www.aukettfitzroyrobinson.com
• Phone: +44-20-78433000
• Fax: N/A
• Employees: 32,200
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.24)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-912,007.41
• Net Margins: -3.86%
• Pretax Margin: N/A
• Return on Equity: -25.00%
• Return on Assets: -1.17%

Debt

• Debt-to-Equity Ratio: 173.23
• Current Ratio: 0.83
• Quick Ratio: 0.63

Sales & Book Value

• Annual Sales: £23.61 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 3.00
• Book Value: GBX 0.87 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 360,208,053
• Free Float: N/A
• Market Cap: £5.46 million
• Optionable: Not Optionable
• Beta: 0.33